TrusScreen Group Limited (TRU) is a medical device company dedicated to improving women's health through early detection of cervical cancer. They've developed and manufacture the TruScreen Ultraâ„¢, an innovative AI-powered device that uses low-level optical and electrical stimuli to detect abnormalities in cervical tissue in real-time. This technology offers a significant advancement in cervical cancer screening, allowing healthcare providers to identify potential problems during routine examinations. TruScreen Ultraâ„¢ is registered as a primary screening device, providing a valuable tool for preventative healthcare.